Federal Register of Legislation - Australian Government

Primary content

PB 74 of 2020 Determinations/Health as made
This instrument amends the National Health (Originator Brand) Determination 2015 (PB 100 of 2015) to determine originator brands of pharmaceutical items for three drugs moving to the F2 formulary on 1 August 2020. It also determines an additional brand of an existing PBS listed drug on the F2 formulary.
Administered by: Health
Registered 31 Jul 2020

PB 74 of 2020

National Health (Originator Brand) Amendment Determination 2020 (No. 4)

National Health Act 1953

I, NIKOLAI TSYGANOV, Acting Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Determination under subsection 99ADB(6B) of the National Health Act 1953.

Dated     30 July 2020

 

 

 

 

 

 

NIKOLAI TSYGANOV

Acting Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health



1              Name of Determination

                 (1)     This Determination is the National Health (Originator Brand) Amendment Determination 2020 (No. 4).

(2)     This Determination may also be cited as PB 74 of 2020.

2              Commencement

                This Determination commences on 1 August 2020.

3              Amendments to PB 100 of 2015

                Schedule 1 amends the National Health (Originator Brand) Determination 2015 (PB 100 of 2015).


Schedule 1     Amendments

(section 3)

[1]                   Schedule 1, (after table item 134)

Insert:

134A

Levodopa with carbidopa and entacapone

Stalevo 50/12.5/200mg

Stalevo 75/18.75/200mg

Stalevo 100/25/200mg

Stalevo 125/31.25/200mg

Stalevo 150/37.5/200mg

Stalevo 200/50/200mg

 

 

[2]                   Schedule 1, (after table item 138)

Insert:

138A

Lurasidone

Latuda

 

 

[3]                   Schedule 1, (after table item 163)

Insert:

163A

Nitrofurantoin

Macrodantin

 

 

[4]                   Schedule 1, (table item 207)

Repeal the items:

207

Salbutamol

Ventolin Rotacaps

Ventolin CFC‑free

Ventolin Nebules

 

 

Substitute:

207

Salbutamol

Ventolin Rotacaps

Ventolin CFC‑free

Ventolin

Ventolin Nebules